-
Nov 21, 2024 | 00405-7&sz=64)
cell.com | David Hsiehchen |Andrew Elliott |Joanne Xiu |Andreas Seeber |Wafik El-Deiry |Emmanuel S. Antonarakis | +12 more
1Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA2Harold C.
-
Sep 19, 2024 | 
nature.com | Wafik El-Deiry
AbstractMesenchymal stem cells (MSCs) in tumor microenvironment (TME) are crucial for the initiation, development, and metastasis of cancer. The impact and mechanism of MSCs on bladder cancer are uncertain. Here we analyzed 205 patient samples to explore the relationships between tumor-stroma ratio and clinicopathological features. A co-culture model and nude mouse transplantation were used to explore the biological roles and molecular mechanisms of MSCs on bladder cancer cells.
-
Jul 9, 2024 | 
oncodaily.com | Wafik El-Deiry
Rebecca Shatsky shared a post by Paolo Tarantino on X, adding:“Love my good friend Paolo Tarantino’s explanation of Her2 Ultra Low!A must read!”Quoting Paolo Tarantino’s post:“What is HER2 ultra low breast cancer, and why should you care? A thread:First, a little history. The ASCO/CAP guidelines from 2007 defined HER2 IHC 0 as ‘absence of HER2 staining’. In truth, it did not make much difference if the tumor was 0 or 1+, since both were considered ‘negative’ for HER2 protein expression.
-
Jul 9, 2024 | 
oncodaily.com | Wafik El-Deiry
shared a post by on LinkedIn, adding:“This is a significant advancement in melanoma treatment, offering hope to those with limited options. The accelerated approval of lifileucel highlights the potential of innovative therapies in combating challenging diseases.
-
Jul 9, 2024 | 
oncodaily.com | Wafik El-Deiry
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:“Vincenzo Cardinale on what ENS-CCA achieved on prior COST Action. expert consensus. clinical impact. patient education. training. Lessons learned applied for Precision-BTC-Network to be even more sucesfull.”Source: Angela Lamarca/X
-
Jul 9, 2024 | 
oncodaily.com | Wafik El-Deiry
Christine Hodgdon, Breast Cancer Survivor and Advocate treated at Johns Hopkins, shared on X:“We lost Marlena this week- a beautiful, smiley, beloved member of our GRASP (Guiding Researchers and Advocates to Scientific Partnership) team. Our hearts are broken. We are so grateful to Tiah Tomlin for her unwavering support and to Marlena’s care team, especially Kevin Kalinsky who showed incredible compassion.”Source: Christine Hodgdon/X
-
Jul 9, 2024 | 
oncodaily.com | Wafik El-Deiry
National Cancer Institute made the following post on X:“Skin cancer is the most common type of cancer. Several genes and hereditary syndromes have been linked to the development of the disease. To learn more, see our overview of the genetics of Skin Cancer.”
-
Jul 9, 2024 | 
oncodaily.com | Wafik El-Deiry
International Society of Liquid Biopsy made the following post on X:“3 Weeks Left to Submit Your Abstract!The countdown is on! You have until Monday, July 29, 2024 (23:59 CEST) to submit your abstract for ISLB24. Accepted abstracts will be published in The Journal of Liquid Biopsy (JLB). Submit your abstract at https://2024.islb.info/b5dv”Source: International Society of Liquid Biopsy/X
-
Jul 9, 2024 | 
oncodaily.com | Wafik El-Deiry
Jul 9, 2024, 07:57Estela Rodriguez shared on X/Twitter: . “Calling all advocates for Hispanic/Latinx health! Join us this Tuesday 7/9 for a webinar on the importance of clinical trials and cancer screening with National Hispanic Medical Association and ACSCAN Florida.
-
Jul 9, 2024 | 
oncodaily.com | Wafik El-Deiry
Kimryn Rathmell shared on X:“Big announcement from FDA regarding diversity in clinical trials. U.S. FDA has drafted long-awaited guidance aimed at empowering drug companies and medical device makers to enroll more people of color and women in clinical trials.”Additional information. Source: Kimryn Rathmell/XDr. Kimryn Rathmell is a distinguished leader and researcher in the field of kidney cancer. Specializing in the research and treatment of complex and hereditary kidney cancers.
